Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Corbus Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics for endocannabinoid or immune system. The company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designe... Corbus Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics for endocannabinoid or immune system. The company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.12 | -1.73661360347 | 6.91 | 7.23 | 6.375 | 173849 | 6.7865704 | CS |
| 4 | -1.565 | -18.7312986236 | 8.355 | 9.41 | 6.375 | 266678 | 7.60907768 | CS |
| 12 | -6.35 | -48.3257229833 | 13.14 | 13.46 | 6.375 | 253538 | 9.98151751 | CS |
| 26 | -49.37 | -87.9095441595 | 56.16 | 56.93 | 6.375 | 469212 | 17.23091262 | CS |
| 52 | -38.52 | -85.0143456191 | 45.31 | 61.9 | 6.375 | 362939 | 28.36437662 | CS |
| 156 | -5.21 | -43.4166666667 | 12 | 61.9 | 2.11 | 948249 | 10.53693332 | CS |
| 260 | -101.51 | -93.730378578 | 108.3 | 322.5 | 2.11 | 2145988 | 57.20557071 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
